Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Secular Trends in Incidence, Modality and Mortality with Dialysis Receiving AKI in Children in Ontario: A Population-Based Cohort Study.

Chanchlani R, Nash DM, McArthur E, Zappitelli M, Archer V, Kuwornu JP, Garg AX, Greenberg JH, Goldstein SL, Thabane L, Wald R.

Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1288-1296. doi: 10.2215/CJN.08250718. Epub 2019 Aug 23.

PMID:
31444174
2.

Comparing health status, disability, and access to care in older and younger inmates in the New South Wales corrections system.

Field C, Archer V.

Int J Prison Health. 2019 Jun 10;15(2):153-161. doi: 10.1108/IJPH-04-2018-0017. Epub 2019 Mar 11.

PMID:
31172851
3.

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.

West H, McCleod M, Hussein M, Morabito A, Rittmeyer A, Conter HJ, Kopp HG, Daniel D, McCune S, Mekhail T, Zer A, Reinmuth N, Sadiq A, Sandler A, Lin W, Ochi Lohmann T, Archer V, Wang L, Kowanetz M, Cappuzzo F.

Lancet Oncol. 2019 Jul;20(7):924-937. doi: 10.1016/S1470-2045(19)30167-6. Epub 2019 May 20.

PMID:
31122901
4.

Importance of considering soils in seed transfer zone development: evidence from a study of the native Bromus marginatus.

Gibson A, Nelson CR, Rinehart S, Archer V, Eramian A.

Ecol Appl. 2019 Mar;29(2):e01835. doi: 10.1002/eap.1835. Epub 2019 Jan 14.

PMID:
30644139
5.

[Impact of an automated dispensing system for medical devices in cardiac surgery department].

Clou E, Dompnier M, Kably B, Leplay C, Poupon E, Archer V, Paul M.

Ann Pharm Fr. 2018 Jan;76(1):64-70. doi: 10.1016/j.pharma.2017.10.003. Epub 2017 Nov 23. French.

PMID:
29174609
6.

Tumor volume measurement error using computed tomography imaging in a phase II clinical trial in lung cancer.

Henschke CI, Yankelevitz DF, Yip R, Archer V, Zahlmann G, Krishnan K, Helba B, Avila R.

J Med Imaging (Bellingham). 2016 Jul;3(3):035505. doi: 10.1117/1.JMI.3.3.035505. Epub 2016 Sep 20.

7.

Implementation of automated dispensing cabinets for management of medical devices in an intensive care unit: organisational and financial impact.

Bourcier E, Madelaine S, Archer V, Kramp F, Paul M, Astier A.

Eur J Hosp Pharm. 2016 Mar;23(2):86-90. doi: 10.1136/ejhpharm-2014-000604. Epub 2015 Sep 8.

8.

Clinical genotyping and efficacy outcomes: exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer.

Pallaud C, Reck M, Juhasz E, Szima B, Yu CJ, Burdaeva O, Orlov S, Hilton M, Archer V, Mok T.

Lung Cancer. 2014 Oct;86(1):67-72. doi: 10.1016/j.lungcan.2014.07.019. Epub 2014 Aug 2.

PMID:
25154982
9.

A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: results of the phase II randomized ABIGAIL study (BO21015).

Mok T, Gorbunova V, Juhasz E, Szima B, Burdaeva O, Orlov S, Yu CJ, Archer V, Hilton M, Delmar P, Pallaud C, Reck M.

J Thorac Oncol. 2014 Jun;9(6):848-55. doi: 10.1097/JTO.0000000000000160.

10.

Heroin use impairs smoking cessation among Australian prisoners.

Indig D, Wodak AD, Richmond RL, Butler TG, Archer VA, Wilhelm KA.

BMC Public Health. 2013 Dec 19;13:1200. doi: 10.1186/1471-2458-13-1200.

11.

[Evaluation of ownership of an implantable medical device by patients].

Salles M, Amet D, Archer V, Elbaz N, Teiger E, Paul M, Astier A.

Ann Pharm Fr. 2013 Nov;71(6):423-8. doi: 10.1016/j.pharma.2013.06.004. Epub 2013 Oct 14. French.

PMID:
24206595
12.

Adult ADHD Among NSW Prisoners: Prevalence and Psychiatric Comorbidity.

Moore E, Sunjic S, Kaye S, Archer V, Indig D.

J Atten Disord. 2016 Nov;20(11):958-967. Epub 2013 Oct 17.

PMID:
24134874
13.

Safety of a novel high tibial osteotomy locked plate fixation for immediate full weight-bearing: a case-control study.

Hernigou P, Queinnec S, Picard L, Guissou I, Naanaa T, Duffiet P, Julian D, Archer V.

Int Orthop. 2013 Dec;37(12):2377-84. doi: 10.1007/s00264-013-2066-3. Epub 2013 Aug 24.

14.

Implementation of a smoke-free policy in a high secure mental health inpatient facility: staff survey to describe experience and attitudes.

Hehir AM, Indig D, Prosser S, Archer VA.

BMC Public Health. 2013 Apr 8;13:315. doi: 10.1186/1471-2458-13-315.

15.

Smoking and other drug characteristics of aboriginal and non-aboriginal prisoners in australia.

Richmond RL, Indig D, Butler TG, Wilhelm KA, Archer VA, Wodak AD.

J Addict. 2013;2013:516342. doi: 10.1155/2013/516342. Epub 2013 Mar 31.

16.

A randomized controlled trial of a smoking cessation intervention conducted among prisoners.

Richmond R, Indig D, Butler T, Wilhelm K, Archer V, Wodak A.

Addiction. 2013 May;108(5):966-74. doi: 10.1111/add.12084. Epub 2013 Mar 11.

17.

Evaluation of a smoke-free forensic hospital: patients' perspectives on issues and benefits.

Hehir AM, Indig D, Prosser S, Archer VA.

Drug Alcohol Rev. 2012 Jul;31(5):672-7. doi: 10.1111/j.1465-3362.2012.00456.x. Epub 2012 Apr 24.

PMID:
22524262
18.

The challenges of reducing tobacco use among prisoners.

Richmond RL, Butler TG, Indig D, Wilhelm KA, Archer VA, Wodak AD.

Drug Alcohol Rev. 2012 Jul;31(5):625-30. doi: 10.1111/j.1465-3362.2012.00435.x. Epub 2012 Mar 26. Review.

PMID:
22449020
19.

Cardiovascular risk among Aboriginal and non-Aboriginal smoking male prisoners: inequalities compared to the wider community.

Richmond RL, Wilhelm KA, Indig D, Butler TG, Archer VA, Wodak AD.

BMC Public Health. 2011 Oct 10;11:783. doi: 10.1186/1471-2458-11-783.

20.

Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL).

Reck M, von Pawel J, Zatloukal P, Ramlau R, Gorbounova V, Hirsh V, Leighl N, Mezger J, Archer V, Moore N, Manegold C; BO17704 Study Group.

Ann Oncol. 2010 Sep;21(9):1804-9. doi: 10.1093/annonc/mdq020. Epub 2010 Feb 11.

21.

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.

Reck M, von Pawel J, Zatloukal P, Ramlau R, Gorbounova V, Hirsh V, Leighl N, Mezger J, Archer V, Moore N, Manegold C.

J Clin Oncol. 2009 Mar 10;27(8):1227-34. doi: 10.1200/JCO.2007.14.5466. Epub 2009 Feb 2. Erratum in: J Clin Oncol. 2009 May 10;27(14):2415.

PMID:
19188680
22.

Indoor radon and lung cancer risk in connecticut and utah.

Sandler DP, Weinberg CR, Shore DL, Archer VE, Stone MB, Lyon JL, Rothney-Kozlak L, Shepherd M, Stolwijk JA.

J Toxicol Environ Health A. 2006 Apr;69(7):633-54.

PMID:
16608830
23.

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer).

Thatcher N, Chang A, Parikh P, Rodrigues Pereira J, Ciuleanu T, von Pawel J, Thongprasert S, Tan EH, Pemberton K, Archer V, Carroll K.

Lancet. 2005 Oct 29-Nov 4;366(9496):1527-37.

PMID:
16257339
24.

Latency and the lung cancer epidemic among United States uranium miners.

Archer VE, Coons T, Saccomanno G, Hong DY.

Health Phys. 2004 Nov;87(5):480-9.

PMID:
15551786
25.
26.

A retrospective evaluation of the feasibility of intrapatient dose escalation as appropriate methodology for dose-ranging studies for combination cytotoxic regimens.

Jordan SD, Poole CJ, Archer VR, Steven NM, Burton A.

Cancer Chemother Pharmacol. 2003 Aug;52(2):113-8. Epub 2003 May 29.

PMID:
12783201
27.

Does dietary sugar and fat influence longevity?

Archer VE.

Med Hypotheses. 2003 Jun;60(6):924-9.

PMID:
12699727
28.

Capsaicin pepper, cancer and ethnicity.

Archer VE, Jones DW.

Med Hypotheses. 2002 Oct;59(4):450-7.

PMID:
12208187
29.

Combined results from three phase II trials of neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus.

Archer VR, Mulholland PJ, Stocken DD, Darnton SJ, Ferry DR.

Clin Oncol (R Coll Radiol). 2001;13(3):164-9.

PMID:
11527288
30.

Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects.

Lebrun-Vignes B, Archer VC, Diquet B, Levron JC, Chosidow O, Puech AJ, Warot D.

Br J Clin Pharmacol. 2001 May;51(5):443-50.

31.

The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy.

Grumett SA, Archer VR, Midgley R, Mulholland P, Nicum S, Blewitt L, Kerr DJ.

Ann Oncol. 2001 Apr;12(4):575. No abstract available.

PMID:
11398896
32.

Radon progeny exposure and lung cancer risk among non-smoking uranium miners.

Gilliland FD, Hunt WC, Archer VE, Saccomanno G.

Health Phys. 2000 Oct;79(4):365-72.

PMID:
11007458
33.
34.

Palliative chemotherapy: no longer a contradiction in terms.

Archer VR, Billingham LJ, Cullen MH.

Oncologist. 1999;4(6):470-7. Review.

35.

Re: Thyroid cancer rates and (131)I doses from Nevada atmospheric nuclear bomb tests.

Archer VE.

J Natl Cancer Inst. 1999 Aug 18;91(16):1423-5. No abstract available.

PMID:
10451455
36.

Cancer death rates and background radiation.

Archer VE.

Health Phys. 1999 Jun;76(6):692-5. No abstract available.

PMID:
10334587
37.

Errors in Cohen's home radon-lung cancer analyses.

Archer VE.

Health Phys. 1998 Dec;75(6):652-4. No abstract available.

PMID:
9827514
38.

Chronic diffuse interstitial fibrosis of the lung in uranium miners.

Archer VE, Renzetti AD, Doggett RS, Jarvis JQ, Colby TV.

J Occup Environ Med. 1998 May;40(5):460-74. Review.

PMID:
9604184
39.

Response to Cohen's plea for help.

Archer VE.

Health Phys. 1997 Sep;73(3):530-2. No abstract available.

PMID:
9287100
40.

Residential radon and lung cancer in Sweden.

Archer VE.

Health Phys. 1997 Aug;73(2):394-5. No abstract available.

PMID:
9228179
41.

Radon, silicosis, and lung cancer.

Archer VE.

Health Phys. 1996 Feb;70(2):268-9. No abstract available.

PMID:
8567296
42.

Re: "Case-control study of residential radon and lung cancer in Winnipeg, Manitoba, Canada".

Archer VE.

Am J Epidemiol. 1995 Oct 15;142(8):884-6. No abstract available.

PMID:
7572965
43.

Reversal of the Healthy-worker Effect.

Archer VE.

Int J Occup Environ Health. 1995 Jan;1(1):33-36.

PMID:
9990155
44.

Cysteine-rich LIM domains of LIM-homeodomain and LIM-only proteins contain zinc but not iron.

Archer VE, Breton J, Sanchez-Garcia I, Osada H, Forster A, Thomson AJ, Rabbitts TH.

Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):316-20.

45.

Re: Harmonization of radon jargon and units.

Archer VE.

Health Phys. 1994 Jan;66(1):91-2. No abstract available.

PMID:
8253585
46.

Spurious bias in the attribution of lung cancer as a cause of death.

Archer VE.

Epidemiology. 1993 Nov;4(6):562-3. No abstract available.

PMID:
8268293
47.

Tich: a mutant causing disproportional growth in the mouse.

Archer JR, Archer VA, Festing MF, Ghiraldini MA.

Genet Res. 1991 Feb;57(1):29-35.

PMID:
2040451
48.

Air pollution and fatal lung disease in three Utah counties.

Archer VE.

Arch Environ Health. 1990 Nov-Dec;45(6):325-34.

PMID:
2270951
49.
50.

Liquid chromatography of lanthanide chelates of 1-(p-nitrophenyl)ethylenediamine-N,N,N',N' -tetra-acetic acid.

Mulero O, Nelson DA, Archer VS, Miknis G, Beckett JR, McLean HL.

Talanta. 1990 Apr;37(4):381-4.

PMID:
18964955

Supplemental Content

Loading ...
Support Center